elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q57029311-2BB9D1D8-EF90-4904-B3C0-43F5C90D61F9
Q57029311-2BB9D1D8-EF90-4904-B3C0-43F5C90D61F9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57029311-2BB9D1D8-EF90-4904-B3C0-43F5C90D61F9
The DILfrequency study is an adaptive trial to identify optimal IL-2 dosing in patients with type 1 diabetes
P932
Q57029311-2BB9D1D8-EF90-4904-B3C0-43F5C90D61F9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57029311-2BB9D1D8-EF90-4904-B3C0-43F5C90D61F9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
16b75de4eecb2afe3fe4174d33a468fa2f30f7ed
P932
6237447
http://www.w3.org/2001/XMLSchema#string